KineMed Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:KineMed Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010905
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. It utilizes isotope labeling, mass spectrometry, and other techniques to observe the activity of biochemical pathways, measure molecular fluxes within the pathways, and to monitor the appearance and disappearance of individual proteins and biological biomarkers. Kinmed develops drugs in the therapeutic areas of muscle metabolism, fibrosis, immunity, neurobiology, diabetes, cancer, and others. The company also conducts pharmaceutical research on molecular targets and deconstructed systems. KineMed is headquartered in Emeryville, California, the US.

KineMed Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KineMed Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
KineMed Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
KineMed Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
KineMed Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
KineMed Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
KineMed Inc, Medical Equipment, Deal Details 10
Partnerships 10
KineMed Extends Co-Development Agreement with CHDI Foundation 10
KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 11
KineMed, Isis Pharma And CHDI Foundation Enter Into Co-Development Agreement For Companion Biomarker 12
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 13
KineMed Enters Into Co-Development Agreement With CHDI Foundation 14
KineMed Inc – Key Competitors 15
KineMed Inc – Key Employees 16
KineMed Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
KineMed Inc, Medical Equipment, Key Facts 2
KineMed Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
KineMed Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
KineMed Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
KineMed Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
KineMed Inc, Deals By Market, 2011 to YTD 2017 8
KineMed Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
KineMed Extends Co-Development Agreement with CHDI Foundation 10
KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 11
KineMed, Isis Pharma And CHDI Foundation Enter Into Co-Development Agreement For Companion Biomarker 12
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 13
KineMed Enters Into Co-Development Agreement With CHDI Foundation 14
KineMed Inc, Key Competitors 15
KineMed Inc, Key Employees 16

★海外企業調査レポート[KineMed Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Syndax Pharmaceuticals Inc (SNDX):医療機器:M&Aディール及び事業提携情報
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Bioactive Bone Substitutes Ltd:製品パイプライン分析
    Summary Bioactive Bone Substitutes Ltd (BBS) is a manufacturer of biologically active medical device implants for orthopedic surgery. The company offers technology platforms, artebone, research and development, and patents. Its artebone is made up of an animal source of bone material used for bone r …
  • Ornim Inc-医療機器分野:企業M&A・提携分析
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development, and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow that is used …
  • Perpetual Energy Inc (PMT):企業の財務・戦略的SWOT分析
    Perpetual Energy Inc (PMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Petronet LNG Limited:企業の戦略・SWOT・財務情報
    Petronet LNG Limited - Strategy, SWOT and Corporate Finance Report Summary Petronet LNG Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bottomline Technologies (de), Inc. (EPAY):企業の財務・戦略的SWOT分析
    Bottomline Technologies (de), Inc. (EPAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Enbridge Inc.:企業の戦略・SWOT・財務情報
    Enbridge Inc. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • STATS ChipPAC Pte Ltd:企業の戦略的SWOT分析
    STATS ChipPAC Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Everest Industries Ltd:企業の戦略・SWOT・財務情報
    Everest Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Everest Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NTPC Ltd (NTPC):電力:M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • Triphase Accelerator Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Triphase Accelerator Corp (Triphase Accelerator) is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products comprise marizomib, a brain-penetrant proteasome inhibitor, which is developed in both intravenou …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Embera NeuroTherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Embera NeuroTherapeutics Inc (Embera) is a contract research company that discovers and develops new treatments. The company’s product includes EMB-001, a drug combination for the stress response system and specific brain functions that results in craving and improvement associated with thes …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Entasis Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Entasis Therapeutics Inc (Entasis) discovers and develops anti-infective products for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, a potent inhibitor of class A, C, and D beta-lactamases intended to treat serious gram-negative infections, such as Acin …
  • Tennessee Valley Authority:企業の戦略的SWOT分析
    Tennessee Valley Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務情報
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • U.S. Geothermal Inc. (HTM)-エネルギー分野:企業M&A・提携分析
    Summary U.S. Geothermal Inc. (USG) is a renewable energy company. It develops and produces electricity from geothermal source. The company owns and operates geothermal power projects in Oregon, Nevada, and Idaho. USG also has interests in geothermal plants under development or exploration stages in …
  • CTD Holdings Inc (CTDH):企業の財務・戦略的SWOT分析
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆